Ramipril and Oesophageal infection - a phase IV clinical study of FDA data

Summary:

Oesophageal infection is reported as a side effect among people who take Ramipril (ramipril), especially for people who are male, 60+ old, also take Pantoprazole, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Oesophageal infection when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Oesophageal infection?

Oesophageal infection is found to be associated with 86 drugs and 186 conditions by eHealthMe. Check the latest studies of Oesophageal infection.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 42 people (0.03%) have Oesophageal infection.

Could Ramipril cause Oesophageal infection?

Among these 42 people:

What is the gender of people who have Oesophageal infection when taking Ramipril? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Oesophageal infection when taking Ramipril? *

What are other drugs people take besides Ramipril? *

What are other side effects people have besides Oesophageal infection? *

Malaise (a feeling of general discomfort or uneasiness): 28 people, 66.67%
Fatigue (feeling of tiredness): 28 people, 66.67%
Joint Swelling: 27 people, 64.29%
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 27 people, 64.29%
Drowsiness: 27 people, 64.29%
Peripheral Swelling: 27 people, 64.29%
Pulmonary Embolism (blockage of the main artery of the lung): 27 people, 64.29%
Feeding Disorder (when children refuse to eat certain food groups): 27 people, 64.29%
Dyspnea (difficult or laboured breathing): 27 people, 64.29%
Gait Disturbance: 26 people, 61.90%

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 23 people, 54.76%
Carcinoid Tumor: 7 people, 16.67%
Bone Density Abnormal: 5 people, 11.90%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 2.38%
Polyarteritis Nodosa (progressive disease of connective tissue): 1 person, 2.38%
Neuralgia (pain in one or more nerves): 1 person, 2.38%
Depression: 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Oesophageal infection?

- Check whether Oesophageal infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oesophageal infection:

Oesophageal infection (86 drugs)

Browse all the conditions that are associated with Oesophageal infection:

Oesophageal infection (186 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.